New research indicates that people who come off new GLP-1 drugs like semaglutide or tirzepatide can put back on lost weight far faster than those who end conventional lifestyle regimens.
Published data in a major health publication shows that while obese individuals can lose substantial amounts of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month once they quit.
"People using such treatments need to be cognizant of the risk of rapid weight regain when the medication is stopped," cautioned expert Dr. Susan Jebb.
That rate of recovery implies a reversion to starting mass in about a year and a half.
Analyzing Approaches
The research, which examined 37 of studies involving thousands of patients, compared the outcomes of GLP-1 agonists with older methods.
Researchers point out that people who shed pounds through dieting generally experience a more gradual creep back—perhaps 0.1 kg a month—after stopping.
Explaining the Fast Rebound
Nutrition scientists propose the way of the jabs is key to understanding the amplified weight return.
The injections mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing the hormone concentrations several times higher than normal might result in the system to produce less of its own natural hormone, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' leads to hunger is uncontrolled, making overeating far more likely."
An Ongoing Disease?
Health authorities advise the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians argue that, due to the high risk of weight regain, the therapy should be considered ongoing.
This view is supported by pharmaceutical companies, who say that the findings "highlight the chronic nature of obesity," comparing it to managing diseases like high blood pressure.
Patient Testimonies
People who have discontinued the jabs explain a powerful return of appetite.
"It felt as if something activating and I was suddenly starving," said one woman.
This challenge is exacerbated if patients have not established permanent lifestyle or habit changes during therapy.
Growing Adoption
Figures show that millions of people in the UK have used weight-loss jabs in the past year, with demand being substantial.
- Adoption is greater among women than males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
Ultimately, experts caution that while GLP-1 drugs are effective agents for shedding pounds, they are not a standalone fix and maintained weight loss relies on integrated lifestyle changes.
